Charité University Hospital — ERA-LEARN

Skip to content
Skip to footer

Service Navigation

Home
About
Contact
newsalert
Twitter

Main Menu Search

Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Home
Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Clinical utility of tumour heterogeneity in triple negative breast cancer and high-grade serous ovarian carcinoma for prediction of therapy response

Home
Explore Partnerships
Partnerships
TRANSCAN-2
Joint Transnational Call for Proposals (JTC 2014)
Clinical utility of tumour heterogeneity in triple negative breast cancer and high-grade serous ovarian carcinoma for prediction of therapy response
Charité University Hospital

Full name	Charité University Hospital
Short name
Type of organisation
Partner Role	Coordinator
Country	Germany

Back to project overview

ERA-LEARN has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 811171.

Sitemap
Imprint
Privacy Policy
Submit accessibility issues
Accessibility Statement

Follow us on Twitter
@ERALEARN_EU

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.